D E Shaw & Co LP Form 8.3 - Allergan Plc (5314M)
11 5월 2020 - 11:00PM
UK Regulatory
TIDMTTM TIDM0Y7T
RNS Number : 5314M
D E Shaw & Co LP
11 May 2020
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing D. E. Shaw & Co., L.P.
(Note 1)
Company dealt in Allergan plc
=========================
Class of relevant security US$0.0001 ordinary shares
to which the dealings
being disclosed relate
(Note 2)
=========================
Date of dealing May 08, 2020
=========================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the
class of relevant
security dealt in (Note 3)
US$0.0001 ordinary Long Short
shares
Number (%) Number (%)
=========== ======= =========== ======
(1) Relevant securities 779,249 (0.23%) 1,918 (0.00%)
==================== ===================
(2) Derivatives (other
than options) 2,887,118 (0.87%)
==================== ===================
(3) Options and agreements
to purchase/sell 32,300 (0.00%)
==================== ===================
Total 3,666,367 (1.11%) 34,218 (0.01%)
==================== ===================
(b) Interests and short positions in relevant securities of the
company, other than the class dealt
in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
========= ====== =========== ======
(1) Relevant securities
=================== =====================
(2) Derivatives (other
than options)
=================== =====================
(3) Options and agreements
to purchase/sell
=================== =====================
Total
=================== =====================
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
(Note 5)
Sale 100 USD 191.87
----------------------------- --------------
Sale 100 USD 191.93
----------------------------- --------------
Sale 100 USD 192.13
----------------------------- --------------
Sale 200 USD 192.35
----------------------------- --------------
Sale 100 USD 192.43
----------------------------- --------------
Sale 100 USD 192.55
----------------------------- --------------
Sale 100 USD 192.69
----------------------------- --------------
Sale 100 USD 192.73
----------------------------- --------------
Sale 200 USD 192.76
----------------------------- --------------
Sale 100 USD 192.88
----------------------------- --------------
Purchase 100 USD 192.72
----------------------------- --------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money paid/received
e.g. call purchasing, to which European per unit
option varying the option etc. (Note 5)
etc. relates (Note
7)
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new
securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options
or derivatives
Full details of any agreement, arrangement or
understanding between the person disclosing and
any other person relating to the voting rights
of any relevant securities under any option referred
to on this form or relating to the voting rights
or future acquisition or disposal of any relevant
securities to which any derivative referred to
on this form is referenced. If none, this should
be stated.
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure May 11, 2020
Contact name Kevin Krist (Compliance
Department)
=======================
Telephone number +44 (0) 20 7409 4420
=======================
If a connected EFM, name
of offeree/offeror with
which connected
=======================
If a connected EFM, state
nature of connection (Note
10)
=======================
Ap23
SUPPLEMENTAL FORM 8
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER
PANEL ACT, 1997, TAKEOVER RULES, 2013
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form
8.1(b)(ii) or Form 8.3,
as appropriate)
OPEN POSITIONS (Note 1)
Product Written, Number of relevant Exercise Type, e.g. Expiry date
name, or purchased securities price (Note American, European
e.g. to which the 2) etc.
call option or derivative
option relates
Put Option Purchased 5,000 USD 110 American 20210115
------------- --------------------- ------------ ------------------- -----------
Put Option Purchased 10,000 USD 120 American 20210115
------------- --------------------- ------------ ------------------- -----------
Put Option Purchased 10,000 USD 135 American 20210115
------------- --------------------- ------------ ------------------- -----------
Put Option Purchased 7,300 USD 140 American 20210115
------------- --------------------- ------------ ------------------- -----------
Notes
1. Where there are open option positions or open derivative
positions (except for CFDs), full
details should be given. Full
details of any existing agreements to purchase or to sell must
also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For full details of disclosur e requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
ISEEADSFFSNEEFA
(END) Dow Jones Newswires
May 11, 2020 10:00 ET (14:00 GMT)
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 12월(12) 2024 으로 1월(1) 2025
Allergan (LSE:0Y7T)
과거 데이터 주식 차트
부터 1월(1) 2024 으로 1월(1) 2025
